메뉴 건너뛰기




Volumn 13, Issue 4, 2013, Pages 425-433

Individual treatment response in attention-deficit/hyperactivity disorder: Broadening perspectives and improving assessments

Author keywords

adaptive clinical trial; ADHD; functional impairment; health related quality of life; individualized medicine; patient reported outcome; treatment

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; LISDEXAMFETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; SCOPOLAMINE;

EID: 84875908402     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.31     Document Type: Review
Times cited : (12)

References (65)
  • 1
    • 84870469320 scopus 로고    scopus 로고
    • Fourth edition, Text Revision. American Psychiatric Association, Washington, DC, USA
    • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, Text Revision. American Psychiatric Association, Washington, DC, USA (2000).
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 2
    • 84866449873 scopus 로고    scopus 로고
    • The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review
    • Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics, 490-499 (2012).
    • (2012) Neurotherapeutics , pp. 490-499
    • Willcutt, E.G.1
  • 3
    • 34250832736 scopus 로고    scopus 로고
    • The worldwide prevalence of ADHD: A systematic review and metaregression analysis
    • Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 164(6), 942-948 (2007).
    • (2007) Am. J. Psychiatry , vol.164 , Issue.6 , pp. 942-948
    • Polanczyk, G.1    De Lima, M.S.2    Horta, B.L.3    Biederman, J.4    Rohde, L.A.5
  • 4
    • 79951671838 scopus 로고    scopus 로고
    • On the way to DSM-V. Eur. Child Adolesc
    • Hebebrand J, Buitelaar JK. On the way to DSM-V. Eur. Child Adolesc. Psychiatry, 57-60 (2011).
    • (2011) Psychiatry , pp. 57-60
    • Hebebrand, J.1    Buitelaar, J.K.2
  • 6
    • 38849168657 scopus 로고    scopus 로고
    • ADHD symptoms vs. impairment: Revisited
    • Barkley RA, Cunningham CE, Gordon M et al. ADHD symptoms vs. impairment: revisited. ADHD Report 14(2), 1-9 (2006).
    • (2006) ADHD Report , vol.14 , Issue.2 , pp. 1-9
    • Barkley, R.A.1    Cunningham, C.E.2    Gordon, M.3
  • 7
    • 76349118545 scopus 로고    scopus 로고
    • Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life
    • Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J. Adolesc. Health 46(3), 209-217 (2010).
    • (2010) J. Adolesc. Health , vol.3 , pp. 209-217
    • Wehmeier, P.M.1    Schacht, A.2    Barkley, R.A.3
  • 8
    • 0035032946 scopus 로고    scopus 로고
    • Preschool children with attention-deficit/hyperactivity disorder: Impairments in behavioral, social, and school functioning
    • DuPaul GJ, McGoey KE, Eckert TL, VanBrakle J. Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J. Am. Acad. Child Adolesc. Psychiatry 40(5), 508-515 (2001).
    • (2001) J. Am. Acad. Child Adolesc. Psychiatry , vol.40 , Issue.5 , pp. 508-515
    • Dupaul, G.J.1    McGoey, K.E.2    Eckert, T.L.3    Vanbrakle, J.4
  • 9
    • 0030007829 scopus 로고    scopus 로고
    • Psychosocial adjustment and educational outcome in adolescents with a childhood diagnosis of attention deficit disorder
    • Wilson JM, Marcotte AC. Psychosocial adjustment and educational outcome in adolescents with a childhood diagnosis of attention deficit disorder. J. Am. Acad. Child Adolesc. Psychiatry 35(5), 579-587 (1996).
    • (1996) J. Am. Acad. Child Adolesc. Psychiatry , vol.35 , Issue.5 , pp. 579-587
    • Wilson, J.M.1    Marcotte, A.C.2
  • 10
    • 79959885081 scopus 로고    scopus 로고
    • Pragmatic measures in paediatric psychopharmacology - Are we getting it right?
    • Coghill D. Pragmatic measures in paediatric psychopharmacology - are we getting it right? Eur. Neuropsychopharmacol. , 571-583 (2011).
    • (2011) Eur Neuropsychopharmacol. , pp. 571-583
    • Coghill, D.1
  • 11
    • 0027496984 scopus 로고
    • Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder
    • Biederman J, Faraone SV, Spencer T et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 150(12), 1798 (1993).
    • (1993) Am. J. Psychiatry , vol.150 , Issue.12 , pp. 1798
    • Biederman, J.1    Faraone, S.V.2    Spencer, T.3
  • 12
    • 84870610053 scopus 로고    scopus 로고
    • Clinical and functional outcome of childhood attention-deficit/ hyperactivity disorder 33 years later
    • Klein RG, Mannuzza S, Olazagasti MA et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch. Gen. Psychiatry 69(12), 1295-1303 (2012).
    • (2012) Arch. Gen. Psychiatry , vol.69 , Issue.12 , pp. 1295-1303
    • Klein, R.G.1    Mannuzza, S.2    Olazagasti, M.A.3
  • 13
    • 84867086560 scopus 로고    scopus 로고
    • Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States
    • Doshi JA, Hodgkins P, Kahle J et al. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J. Am. Acad. Child Adolesc. Psychiatry 51(10), 990-1002.e2 (2012).
    • (2012) J. Am. Acad. Child Adolesc. Psychiatry , vol.51 , Issue.10
    • Doshi, J.A.1    Hodgkins, P.2    Kahle, J.3
  • 14
    • 84858796898 scopus 로고    scopus 로고
    • The lifetime impact of attention deficit hyperactivity disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
    • Bernardi S, Faraone SV, Cortese S et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol. Med. 42(4), 875-887 (2012).
    • (2012) Psychol. Med. , vol.42 , Issue.4 , pp. 875-887
    • Bernardi, S.1    Faraone, S.V.2    Cortese, S.3
  • 15
    • 20544445977 scopus 로고    scopus 로고
    • Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder
    • Brod M, Perwien A, Adler L, Spencer T, Johnston J. Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder. Prim. Psychiatry 12(6), 58-64 (2005).
    • (2005) Prim. Psychiatry , vol.12 , Issue.6 , pp. 58-64
    • Brod, M.1    Perwien, A.2    Adler, L.3    Spencer, T.4    Johnston, J.5
  • 16
    • 84862534589 scopus 로고    scopus 로고
    • The burdened life of adults with ADHD: Impairment beyond comorbidity
    • Garcia CR, Bau CH, Silva KL et al. The burdened life of adults with ADHD: impairment beyond comorbidity. Eur. Psychiatry 27(5), 309-313 (2012).
    • (2012) Eur. Psychiatry , vol.27 , Issue.5 , pp. 309-313
    • Garcia, C.R.1    Bau, C.H.2    Silva, K.L.3
  • 17
    • 84863620521 scopus 로고    scopus 로고
    • ADHD burden of illness in older adults: A life course perspective
    • Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G. ADHD burden of illness in older adults: a life course perspective. Qual. Life Res. 21(5), 795-799 (2012).
    • (2012) Qual. Life Res. , vol.21 , Issue.5 , pp. 795-799
    • Brod, M.1    Schmitt, E.2    Goodwin, M.3    Hodgkins, P.4    Niebler, G.5
  • 18
    • 31644441421 scopus 로고    scopus 로고
    • Symptoms versus impairment: The case for respecting DSM-IV's Criterion D
    • Gordon M, Antshel K, Faraone S et al. Symptoms versus impairment: the case for respecting DSM-IV's Criterion D. J. Atten. Disord. 9(3), 465-475 (2006).
    • (2006) J. Atten. Disord. , vol.9 , Issue.3 , pp. 465-475
    • Gordon, M.1    Antshel, K.2    Faraone, S.3
  • 19
    • 38849189429 scopus 로고    scopus 로고
    • The role of impairment in the diagnosis of ADHD
    • Gathje RA, Lewandowski LJ, Gordon M. The role of impairment in the diagnosis of ADHD. J. Atten. Disord. 11(5), 529-537 (2008).
    • (2008) J. Atten. Disord. , vol.11 , Issue.5 , pp. 529-537
    • Gathje, R.A.1    Lewandowski, L.J.2    Gordon, M.3
  • 20
    • 77952121726 scopus 로고    scopus 로고
    • Quality of life and attentiondeficit/ hyperactivity disorder core symptoms: A pooled analysis of 5 non-US atomoxetine clinical trials
    • Escobar R, Schacht A, Wehmeier PM, Wagner T. Quality of life and attentiondeficit/ hyperactivity disorder core symptoms: a pooled analysis of 5 non-US atomoxetine clinical trials. J. Clin. Psychopharmacol. 30(2), 145-151 (2010).
    • (2010) J. Clin. Psychopharmacol. , vol.30 , Issue.2 , pp. 145-151
    • Escobar, R.1    Schacht, A.2    Wehmeier, P.M.3    Wagner, T.4
  • 21
    • 77950350304 scopus 로고    scopus 로고
    • The quality of life of children with attention deficit/hyperactivity disorder: A systematic review
    • Danckaerts M, Sonuga-Barke EJ, Banaschewski T et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur. Child Adolesc. Psychiatry 19(2), 83-105 (2010).
    • (2010) Eur. Child Adolesc. Psychiatry , vol.19 , Issue.2 , pp. 83-105
    • Danckaerts, M.1    Sonuga-Barke, E.J.2    Banaschewski, T.3
  • 22
    • 68849127985 scopus 로고    scopus 로고
    • Practitioner review: Quality of life in child mental health - Conceptual challenges and practical choices
    • ADHD European Guidelines Group.
    • Coghill D, Danckaerts M, Sonuga-Barke E, Sergeant J; ADHD European Guidelines Group. Practitioner review: quality of life in child mental health - conceptual challenges and practical choices. J. Child Psychol. Psychiatry 50(5), 544-561 (2009).
    • (2009) J. Child Psychol. Psychiatry , vol.50 , Issue.5 , pp. 544-561
    • Coghill, D.1    Danckaerts, M.2    Sonuga-Barke, E.3    Sergeant, J.4
  • 23
    • 79551648562 scopus 로고    scopus 로고
    • Impact of the impairment criterion in the diagnosis of adult ADHD: 33-year follow-up study of boys with ADHD
    • Mannuzza S, Castellanos FX, Roizen ER, Hutchison JA, Lashua EC, Klein RG. Impact of the impairment criterion in the diagnosis of adult ADHD: 33-year follow-up study of boys with ADHD. J. Atten. Disord. 15(2), 122-129 (2011).
    • (2011) J. Atten. Disord. , vol.15 , Issue.2 , pp. 122-129
    • Mannuzza, S.1    Castellanos, F.X.2    Roizen, E.R.3    Hutchison, J.A.4    Lashua, E.C.5    Klein, R.G.6
  • 24
    • 84862118810 scopus 로고    scopus 로고
    • Systematic review of national and international guidelines on attention-deficit hyperactivity disorder
    • Seixas M, Weiss M, Müller U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J. Psychopharmacol. (Oxford) , 753-765 (2012).
    • (2012) J. Psychopharmacol. (Oxford) , pp. 753-765
    • Seixas, M.1    Weiss, M.2    Müller, U.3
  • 25
    • 77956703527 scopus 로고    scopus 로고
    • The impact of medications on quality of life in attention-deficit hyperactivity disorder: A systematic review
    • Coghill D. The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 24(10), 843-866 (2010).
    • (2010) CNS Drugs , vol.24 , Issue.10 , pp. 843-866
    • Coghill, D.1
  • 26
    • 84877919585 scopus 로고    scopus 로고
    • Do stimulants improve functioning in adults with ADHD? A review of the literature
    • doi:10.1016/jeuroneuro.2012.02.010 Epub ahead of print
    • Surman C, Hammerness P, Pion K, Faraone S. Do stimulants improve functioning in adults with ADHD? A review of the literature. Eur. Neuropsychopharmacol. doi:10.1016/j. euroneuro.2012.02.010 (2013) (Epub ahead of print).
    • (2013) Eur. Neuropsychopharmacol.
    • Surman, C.1    Hammerness, P.2    Pion, K.3    Faraone, S.4
  • 27
    • 84874908692 scopus 로고    scopus 로고
    • Assessing treatment outcomes in attention-deficit/ hyperactivity disorder: A narrative review
    • Epstein JN, Weiss MD. Assessing treatment outcomes in attention-deficit/ hyperactivity disorder: a narrative review. Prim. Care Comp. CNS Disord. 14(6), e1-e15 (2012).
    • (2012) Prim. Care Comp. CNS Disord. , vol.14 , Issue.6
    • Epstein, J.N.1    Weiss, M.D.2
  • 28
    • 0032753828 scopus 로고    scopus 로고
    • A 14-month randomized clinical trial of treatment strategies for attentiondeficit/ hyperactivity disorder
    • MTA (Multimodal Treatment Study of Children with ADHD), Cooperative Group
    • MTA (Multimodal Treatment Study of Children with ADHD) Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attentiondeficit/ hyperactivity disorder. Arch. Gen. Psychiatry. 56(12), 1073-1086 (1999).
    • (1999) Arch. Gen. Psychiatry. , vol.56 , Issue.12 , pp. 1073-1086
  • 29
    • 56749111241 scopus 로고    scopus 로고
    • NICE. Attention Deficit Hyperactivity Disorder National Clinical Practice Guideline Number 72, The British Psychological Society and The Royal College of Psychiatrists, Leicester, UK
    • NICE. Attention Deficit Hyperactivity Disorder. Diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. The British Psychological Society and The Royal College of Psychiatrists, Leicester, UK (2009).
    • (2009) Diagnosis and Management of ADHD in Children, Young People and Adults
  • 30
    • 12444289440 scopus 로고    scopus 로고
    • Evidence- based medicine, heterogeneity of treatment effects, and the trouble with averages
    • Kravitz RL, Duan N, Braslow J. Evidence- based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 82(4), 661-687 (2004).
    • (2004) Milbank Q , vol.82 , Issue.4 , pp. 661-687
    • Kravitz, R.L.1    Duan, N.2    Braslow, J.3
  • 31
    • 25144438496 scopus 로고    scopus 로고
    • Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents
    • Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J. Clin. Child Adolesc. Psychol. 34(3), 449-476 (2005).
    • (2005) J. Clin. Child Adolesc. Psychol. , vol.34 , Issue.3 , pp. 449-476
    • Pelham Jr., W.E.1    Fabiano, G.A.2    Massetti, G.M.3
  • 32
    • 84857818487 scopus 로고    scopus 로고
    • Functional impairments in children with ADHD: Unique effects of age and comorbid status
    • Booster GD, DuPaul GJ, Eiraldi R, Power TJ. Functional impairments in children with ADHD: unique effects of age and comorbid status. J. Atten. Disord. 16(3), 189 (2012).
    • (2012) J. Atten. Disord. , vol.16 , Issue.3 , pp. 189
    • Booster, G.D.1    Dupaul, G.J.2    Eiraldi, R.3    Power, T.J.4
  • 33
    • 79951683563 scopus 로고    scopus 로고
    • Attention-deficit hyperactivity disorder in children with high intelligence quotient: Results from a population-based study
    • Katusic MZ, Voigt RG, Colligan RC, Weaver AL, Homan KJ, Barbaresi WJ. Attention-deficit hyperactivity disorder in children with high intelligence quotient: results from a population-based study. J. Dev. Behav. Pediatr. 32(2), 103-109 (2011).
    • (2011) J. Dev. Behav. Pediatr. , vol.32 , Issue.2 , pp. 103-109
    • Katusic, M.Z.1    Voigt, R.G.2    Colligan, R.C.3    Weaver, A.L.4    Homan, K.J.5    Barbaresi, W.J.6
  • 34
    • 33845769867 scopus 로고    scopus 로고
    • Which factors impact on clinician-rated impairment in children with ADHD?
    • ADORE Study Group
    • Coghill D, Spiel G, Baldursson G et al.; ADORE Study Group. Which factors impact on clinician-rated impairment in children with ADHD? Eur. Child Adolesc. Psychiatry 15(Suppl. 1), I30-I37 (2006).
    • (2006) Eur. Child Adolesc. Psychiatry , vol.15 , Issue.SUPPL. 1
    • Coghill, D.1    Spiel, G.2    Baldursson, G.3
  • 35
    • 84864804936 scopus 로고    scopus 로고
    • A review of executive function deficits and pharmacological management in children and adolescents
    • Hosenbocus S, Chahal R. A review of executive function deficits and pharmacological management in children and adolescents. J. Can. Acad. Child Adolesc. Psychiatry 21(3), 223-229 (2012).
    • (2012) J. Can. Acad. Child Adolesc. Psychiatry , vol.21 , Issue.3 , pp. 223-229
    • Hosenbocus, S.1    Chahal, R.2
  • 36
    • 84863403331 scopus 로고    scopus 로고
    • The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm
    • Biederman J, Fried R, Hammerness P et al. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J. Psychiatr. Res. 46(4), 484-491 (2012).
    • (2012) J. Psychiatr. Res. , vol.46 , Issue.4 , pp. 484-491
    • Biederman, J.1    Fried, R.2    Hammerness, P.3
  • 37
    • 33749047505 scopus 로고    scopus 로고
    • Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder
    • Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Pediatrics 118(3), e704-e710 (2006).
    • (2006) Pediatrics , vol.118 , Issue.3
    • Cox, D.J.1    Merkel, R.L.2    Moore, M.3    Thorndike, F.4    Muller, C.5    Kovatchev, B.6
  • 38
    • 39549108113 scopus 로고    scopus 로고
    • Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)
    • Sobanski E, Sabljic D, Alm B et al. Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/ hyperactivity disorder (ADHD). J. Neural Transm. , 347-356 (2008).
    • (2008) J. Neural Transm. , pp. 347-356
    • Sobanski, E.1    Sabljic, D.2    Alm, B.3
  • 39
    • 0034128418 scopus 로고    scopus 로고
    • Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: A preliminary double-blind placebo controlled trial
    • Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J. Nerv. Ment. Dis. 188(4), 234 (2000).
    • (2000) J. Nerv. Ment. Dis. , vol.188 , Issue.4 , pp. 234
    • Cox, D.J.1    Merkel, R.L.2    Kovatchev, B.3    Seward, R.4
  • 40
    • 84866870004 scopus 로고    scopus 로고
    • A systematic review of global publication trends regarding long-term outcomes of ADHD
    • Hodgkins P, Arnold LE, Shaw M et al. A systematic review of global publication trends regarding long-term outcomes of ADHD. Front. Psychiatry 2, 84 (2011).
    • (2011) Front. Psychiatry , vol.2 , Issue.84
    • Hodgkins, P.1    Arnold, L.E.2    Shaw, M.3
  • 41
    • 84856806918 scopus 로고    scopus 로고
    • Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD
    • Biederman J, Mick E, Spencer T, Surman C, Faraone SV. Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. CNS Neurosci. Ther. 18(2), 126-132 (2012).
    • (2012) CNS Neurosci. Ther. , vol.18 , Issue.2 , pp. 126-132
    • Biederman, J.1    Mick, E.2    Spencer, T.3    Surman, C.4    Faraone, S.V.5
  • 42
    • 0036107419 scopus 로고    scopus 로고
    • Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder
    • Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. J. Clin. Psychopharmacol. 22(3), 267-274 (2002).
    • (2002) J. Clin. Psychopharmacol. , vol.22 , Issue.3 , pp. 267-274
    • Gadow, K.D.1    Nolan, E.E.2    Sverd, J.3    Sprafkin, J.4    Schwartz, J.5
  • 43
    • 84868101082 scopus 로고    scopus 로고
    • Amfetamine and methylphenidate medications for attention- deficit/hyperactivity disorder: Complementary treatment options
    • Hodgkins P, Shaw M, Coghill D, Hechtman L. Amfetamine and methylphenidate medications for attention- deficit/hyperactivity disorder: complementary treatment options. Eur. Child Adolesc. Psychiatry 21(9), 477-492 (2012).
    • (2012) Eur. Child Adolesc. Psychiatry , vol.21 , Issue.9 , pp. 477-492
    • Hodgkins, P.1    Shaw, M.2    Coghill, D.3    Hechtman, L.4
  • 44
    • 39349108186 scopus 로고    scopus 로고
    • Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: Epidemiology, prevention and management
    • Graham J, Coghill D. Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs, 213-237 (2008).
    • (2008) CNS Drugs , pp. 213-237
    • Graham, J.1    Coghill, D.2
  • 45
    • 78651514054 scopus 로고    scopus 로고
    • European guidelines on managing adverse effects of medication for ADHD
    • European Guidelines Group
    • Graham J, Banaschewski T, Buitelaar J et al.; European Guidelines Group. European guidelines on managing adverse effects of medication for ADHD. Eur. Child Adolesc. Psychiatry 20(1), 17-37 (2011).
    • (2011) Eur. Child Adolesc. Psychiatry , vol.20 , Issue.1 , pp. 17-37
    • Graham, J.1    Banaschewski, T.2    Buitelaar, J.3
  • 47
    • 77954725227 scopus 로고    scopus 로고
    • Duration of effect of oral long-acting stimulant medications for ADHD throughout the day
    • Brams M, Moon E, Pucci M, López FA. Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Curr. Med. Res. Opin. , 1809-1825 (2010).
    • (2010) Curr. Med. Res. Opin. , pp. 1809-1825
    • Brams, M.1    Moon, E.2    Pucci, M.3    López, F.A.4
  • 48
    • 56149084870 scopus 로고    scopus 로고
    • Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder
    • Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad. Med. 120(3), 69-88 (2008).
    • (2008) Postgrad. Med. , vol.120 , Issue.3 , pp. 69-88
    • Brams, M.1    Mao, A.R.2    Doyle, R.L.3
  • 49
    • 78649964740 scopus 로고    scopus 로고
    • Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder
    • Ramos-Quiroga JA, Casas M. Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder. CNS Drugs 25(1), 36 (2011).
    • (2011) CNS Drugs , vol.25 , Issue.1 , pp. 36
    • Ramos-Quiroga, J.A.1    Casas, M.2
  • 50
    • 33645740561 scopus 로고    scopus 로고
    • A randomized, controlled effectiveness trial of OROSmethylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder
    • Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROSmethylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can. J. Clin. Pharmacol. 13(1), e50-e62 (2006).
    • (2006) Can. J. Clin. Pharmacol. , vol.13 , Issue.1
    • Steele, M.1    Weiss, M.2    Swanson, J.3    Wang, J.4    Prinzo, R.S.5    Binder, C.E.6
  • 51
    • 42549124220 scopus 로고    scopus 로고
    • Evidencebased psychosocial treatments for attention-deficit/hyperactivity disorder
    • Pelham WE Jr, Fabiano GA. Evidencebased psychosocial treatments for attention-deficit/hyperactivity disorder. J. Clin. Child Adolesc. Psychol. 37(1), 214 (2008).
    • (2008) J. Clin. Child Adolesc. Psychol. , vol.37 , Issue.1 , pp. 214
    • Pelham Jr., W.E.1    Fabiano, G.A.2
  • 52
    • 84857755456 scopus 로고    scopus 로고
    • Attention deficit hyperactivity disorder pharmacogenetics: The dopamine transporter and D4 receptor
    • McGough JJ. Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor. Pharmacogenomics 13(4),368 (2012)
    • (2012) Pharmacogenomics , vol.13 , Issue.4 , pp. 368
    • McGough, J.J.1
  • 54
    • 84869779642 scopus 로고    scopus 로고
    • Identifying patient subgroups who benefit most from a treatment: Using administrative claims data to uncover treatment heterogeneity
    • Erder MH, Signorovitch JE, Setyawan J et al. Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity. J. Med. Econ. , 1078-1087 (2012).
    • (2012) J. Med. Econ. , pp. 1078-1087
    • Erder, M.H.1    Signorovitch, J.E.2    Setyawan, J.3
  • 55
    • 84860602634 scopus 로고    scopus 로고
    • Baseline mood-state measures as predictors of antidepressant response to scopolamine
    • Furey ML, Nugent AC, Speer AM et al. Baseline mood-state measures as predictors of antidepressant response to scopolamine. Psychiatry Res. 196(1), 62-67 (2012).
    • (2012) Psychiatry Res , vol.196 , Issue.1 , pp. 62-67
    • Furey, M.L.1    Nugent, A.C.2    Speer, A.M.3
  • 56
    • 83755207549 scopus 로고    scopus 로고
    • Conference scene: UK pharmacogenetics and stratified medicine network
    • Hall I. Conference scene: UK pharmacogenetics and stratified medicine network. Pharmacogenomics 13(1), 19-20 (2012).
    • (2012) Pharmacogenomics , vol.13 , Issue.1 , pp. 19-20
    • Hall, I.1
  • 57
    • 80051695379 scopus 로고    scopus 로고
    • Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: An efficient, dose-adaptive, seamless Phase II/III design
    • Levin B, Thompson JL, Chakraborty B, Levy G, MacArthur R, Haley EC. Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient, dose-adaptive, seamless Phase II/III design. Clin. Trials, 398-407 (2011).
    • (2011) Clin. Trials , pp. 398-407
    • Levin, B.1    Thompson, J.L.2    Chakraborty, B.3    Levy, G.4    Macarthur, R.5    Haley, E.C.6
  • 58
    • 79953056388 scopus 로고    scopus 로고
    • Adaptive seamless design for an efficacy trial of replicationcompetent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP trial)
    • Lu M, Freytag SO, Stricker H, Kim JH, Barton K, Movsas B. Adaptive seamless design for an efficacy trial of replicationcompetent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP trial). Contemp. Clin. Trials 32(3), 453-460 (2011).
    • (2011) Contemp. Clin. Trials , vol.32 , Issue.3 , pp. 453-460
    • Lu, M.1    Freytag, S.O.2    Stricker, H.3    Kim, J.H.4    Barton, K.5    Movsas, B.6
  • 59
    • 0042385028 scopus 로고    scopus 로고
    • Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment
    • Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P. Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment. J. Clin. Epidemiol. , 736-743 (2003).
    • (2003) J. Clin. Epidemiol. , pp. 736-743
    • Rockwood, K.1    Howlett, S.2    Stadnyk, K.3    Carver, D.4    Powell, C.5    Stolee, P.6
  • 60
    • 78650500542 scopus 로고    scopus 로고
    • Representativeness of participants in a clinical trial for attention-deficit/ hyperactivity disorder? Comparison with adults from a large observational study
    • Surman CB, Monuteaux MC, Petty CR et al. Representativeness of participants in a clinical trial for attention-deficit/ hyperactivity disorder? Comparison with adults from a large observational study. J. Clin. Psychiatry 71(12), 1612-1616 (2010).
    • (2010) J. Clin. Psychiatry , vol.71 , Issue.12 , pp. 1612-1616
    • Surman, C.B.1    Monuteaux, M.C.2    Petty, C.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.